Asia Pacific Donor Blood Component Market Analysis and Forecast by Size, Share, Growth, Trends 2031

The Asia Pacific Donor Blood Component Market size is expected to reach US$ 1,878.3 Million by 2031 from US$ 1,262.3 Million in 2024. The market is estimated to record a CAGR of 6.0% from 2025 to 2031.

Executive Summary and Asia Pacific Donor Blood Component Market Analysis:

The Asia Pacific donor blood component market is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. Rapid population growth and increasing incidences of chronic diseases are creating a higher demand for blood transfusions. Expanding healthcare infrastructure, particularly in emerging economies like India and China, is improving access to blood collection and processing facilities. Government initiatives promoting voluntary blood donation and public awareness campaigns are also boosting donor participation. Furthermore, advancements in blood separation and storage technologies enhance the efficiency and safety of blood component usage. The rise in surgical procedures further contributes to market expansion. Additionally, growing support from international health organizations and collaborations for improved blood banking systems is fostering market development.

Asia Pacific Donor Blood Component Market: Strategic Insights

Asia Pacific Donor Blood Component Market Segmentation Analysis:

• By Blood Component, the Asia Pacific Donor Blood Component Market is segmented into Red Blood Cells, White blood cells, Platelets, Plasma, and Others. Red Blood Cells held the largest share of the market in 2024.
• By Blood Component Volume, the Asia Pacific Donor Blood Component Market is segmented into Red Blood Cells, White blood cells, Platelets, Plasma, and Others. Red Blood Cells held the largest share of the market in 2024.
• By Indication, the Asia Pacific Donor Blood Component Market is segmented into Immunosuppression and Oncology. Immunosuppression held the largest share of the market in 2024.
• By Immunosuppression, the Asia Pacific Donor Blood Component Market is segmented into Organ Transplant, HIV or AIDS, Autoimmune Disease, Cardiovascular Surgeries, Orthopedic Surgeries, and Others. HIV or AIDS held the largest share of the market in 2024.
• By Oncology, the Asia Pacific Donor Blood Component Market is segmented into Hematologic malignancies and Solid Tumor Patients. Hematologic malignancies held the largest share of the market in 2024.
• By Application, the Asia Pacific Donor Blood Component Market is segmented into Anemia management, Thrombocytopenia treatment, Coagulopathy correction, Supportive care during chemotherapy, Surgery, and Others. Anemia management held the largest share of the market in 2024.
• By Age Group, the Asia Pacific Donor Blood Component Market is segmented into Adult and Child. Adult held the largest share of the market in 2024.
• By End User, the Asia Pacific Donor Blood Component Market is segmented into Hospitals, Oncology centers, Transplant centers, Ambulatory surgical centers, and Others. Hospitals held the largest share of the market in 2024.

Asia Pacific Donor Blood Component Market Players Density: Understanding Its Impact on Business Dynamics

The Asia Pacific Donor Blood Component Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

Asia Pacific Donor Blood Component Market Outlook

Increasing donor awareness drives the global donor blood component market by boosting voluntary participation and repeat donations. Educational campaigns help dispel myths and emphasize the life-saving impact of blood donation. Greater awareness ensures a more consistent and sufficient blood supply to meet growing healthcare demands. Public health initiatives, celebrity sponsorships, and community efforts have been instrumental in rallying voluntary blood donation. In 2024, the World Health Organization celebrated the 20th anniversary of World Blood Donor Day with a focus on expressing appreciation to donors and pushing for more involvement globally.

In India, Ahmedabad was notable for its excellent blood donation campaign. The city has 138 centurion blood donors who have donated 100+ times, including India's sole female centurion donor, a centurion couple, and a differently-abled centurion. Ahmedabad has emerged as India's blood donation capital, with Mukesh Patel leading the team with 151 blood donations. Indian Red Cross Society (IRCS), Ahmedabad branch, conducted several blood donation camps in 2023, collecting more than 250,000 units, reflecting the community's support for voluntary blood donation. These efforts highlight the importance of increased awareness among donors in ensuring a stable and adequate blood supply, thus propelling the donor blood component market forward. Increasing donor awareness plays a pivotal role in strengthening the donor blood component market by encouraginga consistent and voluntary donations. Public health campaigns, media involvement, and community-driven initiatives help normalize and promote regular blood donation. Recognizing and rewarding donors fosters long-term engagement and builds a culture of giving. These collective efforts ensure a steady, safe, and sufficient blood supply to meet rising medical demands. Ultimately, sustained awareness and participation are essential for the market's continued growth and resilience.

Asia Pacific Donor Blood Component Market Country Insights

By country, the Asia Pacific Donor Blood Component Market is segmented into China, Japan, India, Australia, South Korea, and the Rest of APAC. China held the largest share in 2024.

After China's 1998 Blood Donation Law came into effect, the country established a fully voluntary, unpaid donation system for citizens and encourages healthy citizens aged from 18 to 55 to donate blood voluntarily. The government covers all costs related to collection, testing, and processing to ensure safety and ethical standards. According to the National Health Commission (NHC), the nation has a blood donation rate of 11.4 per 1,000 people. It recorded 16.99 million voluntary blood donations in 2023. China's current standard allows individuals to donate 200 to 400 milliliters of blood per session, with at least six months between donations. The surging donations reflect the effectiveness of national campaigns and the public awareness regarding the importance of blood donation.

From January to May 2024, Fresenius Kabi China hosted Blood Donation Day activities in several cities nationwide. The campaign attracted a total of 800 participants, donating 52 units of platelets and ~49 liters of whole blood. Since 2013, Fresenius Kabi China has been promoting voluntary blood donation among young people every year on Youth Day. Over the past 12 years, this initiative has engaged 5,726 participants. It has resulted in the donation of 1,242 units of platelets and 514 liters of whole blood. The aging population of the country, coupled with increasing cases of chronic disease and immune deficiencies, boosts the need for blood components, thus supporting the growth of the donor blood component market.

Asia Pacific Donor Blood Component Market Company Profiles

Some of the key players operating in the market include Vitalant, Memorial Sloan Kettering Cancer Center, Roswell Park Comprehensive Cancer Center, Policlinico of Milan, MD Anderson Cancer Center., The Johns Hopkins Hospital, The Royal Marsden, Gustave Roussy, Peter MacCallum Cancer Centre, and Tata Memorial Hospital

These players are adopting various strategies such as expansion, product innovation, and mergers and acquisitions to provide innovative products to their consumers and increase their market share.

Asia Pacific Donor Blood Component Market Research Methodology

The following methodology has been followed for the collection and analysis of data presented in this report:

Secondary Research

The research process begins with comprehensive secondary research, utilizing internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:

• Company websites, annual reports, financial statements, broker analyses, and investor presentations
• Industry trade journals and other relevant publications
• Government documents, statistical databases, and market reports
• News articles, press releases, and webcasts specific to companies operating in the market

Note:

Primary Research

The Insight Partners conducts a significant number of primary interviews each year with industry stakeholders and experts to validate its data analysis and gain valuable insights. These research interviews are designed to:

• Validate and refine findings from secondary research
• Enhance the expertise and market understanding of the analysis team
• Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects

Primary research is conducted via email interactions and telephone interviews, encompassing various markets, categories, segments, and sub-segments across different regions. Participants typically include:

• Industry stakeholders: Vice Presidents, Business Development Managers, Market Intelligence Managers, and National Sales Managers
• External experts: Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise